Sodium–glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report
Background: Sodium–glucose cotransporter 2 inhibitors are among the new-generation oral antihyperglycemic agents that have been used in the treatment of type 2 diabetes mellitus. With the recent coronavirus disease 2019 pandemic and rise of cases in the third wave, diagnosis of life-threatening eugl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
BioMed Central
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/43189/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|